Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 222 entries
Sorted by: Best Match Show Resources per page
Comparison of implementation strategies to influence adherence to the clinical pathway for screening, assessment and management of anxiety and …

Science interventions

Butow P, Shaw J, Shepherd HL.
GSID: 1nQS82jh9BMJ
P Butow, J Shaw, HL Shepherd, M Price, L Masya… - BMC cancer, 2018 - Springer

Health service change is difficult to achieve. One strategy to facilitate such change is the clinical pathway, a guide for clinicians containing a defined set of evidence-based …

Cite
Butow, P., Shaw, J., Shepherd, H. L., Price, M., Masya, L., Kelly, B., ... & White, F. (2018). Comparison of implementation strategies to influence adherence to the clinical pathway for screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP): study protocol of a cluster randomised controlled trial. BMC cancer, 18(1), 1-12.
Butow, Phyllis, et al. "Comparison of implementation strategies to influence adherence to the clinical pathway for screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP): study protocol of a cluster randomised controlled trial." BMC cancer 18.1 (2018): 1-12.
Copy Download .nbib Format: MLA
Everybody wants it done but nobody wants to do it: an exploration of the barrier and enablers of critical components towards creating a clinical pathway for …

Science interventions

Butow PN, Rankin NM.
GSID: nh8nEwlARRoJ
NM Rankin, PN Butow, T Thein, T Robinson… - BMC Health Services …, 2015 - Springer

This study aimed to explore barriers to and enablers for future implementation of a draft clinical pathway for anxiety and depression in cancer patients in the Australian context …

Cite
Rankin, N. M., Butow, P. N., Thein, T., Robinson, T., Shaw, J. M., Price, M. A., ... & Grimison, P. (2015). Everybody wants it done but nobody wants to do it: an exploration of the barrier and enablers of critical components towards creating a clinical pathway for anxiety and depression in cancer. BMC Health Services Research, 15(1), 1-8.
Rankin, Nicole M., et al. "Everybody wants it done but nobody wants to do it: an exploration of the barrier and enablers of critical components towards creating a clinical pathway for anxiety and depression in cancer." BMC Health Services Research 15.1 (2015): 1-8.
Copy Download .nbib Format: MLA
Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet

Educational trials

Ellis PM, Butow PN.
GSID: IVNTz2fq6b0J
PM Ellis, PN Butow, MHN Tattersall - Annals of oncology, 2002 - Elsevier

… clinical trials (RCTs) and were randomized to receive usual information treatment options provided from their oncologist, or the educational … Fewer women who received the clinical trials booklet (40% versus 47%) would consider participating in the hypothetical clinical...

Cite
Ellis, P. M., Butow, P. N., & Tattersall, M. H. N. (2002). Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet. Annals of oncology, 13(9), 1414-1423.
Ellis, P. M., P. N. Butow, and M. H. N. Tattersall. "Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet." Annals of oncology 13.9 (2002): 1414-1423.
Copy Download .nbib Format: MLA
Harnessing the potential to quantify public preferences for healthcare priorities through citizens' juries.

International journal of health policy and management

Whitty JA, Burton P, Kendall E, Ratcliffe J, Wilson A, Littlejohns P, Scuffham PA.
PMID: 25114943
Int J Health Policy Manag. 2014 Jun 16;3(2):57-62. doi: 10.15171/ijhpm.2014.61. eCollection 2014 Jul.

Despite progress towards greater public engagement, questions about the optimal approach to access public preferences remain unanswered. We review two increasingly popular methods for engaging the public in healthcare priority-setting and determining their preferences; the Citizens' Jury (CJ) and...

Cite
Whitty JA, Burton P, Kendall E, et al. Harnessing the potential to quantify public preferences for healthcare priorities through citizens' juries. Int J Health Policy Manag. 2014;3(2):57-62doi: 10.15171/ijhpm.2014.61.
Whitty, J. A., Burton, P., Kendall, E., Ratcliffe, J., Wilson, A., Littlejohns, P., & Scuffham, P. A. (2014). Harnessing the potential to quantify public preferences for healthcare priorities through citizens' juries. International journal of health policy and management, 3(2), 57-62. https://doi.org/10.15171/ijhpm.2014.61
Whitty, Jennifer A, et al. "Harnessing the potential to quantify public preferences for healthcare priorities through citizens' juries." International journal of health policy and management vol. 3,2 (2014): 57-62. doi: https://doi.org/10.15171/ijhpm.2014.61
Whitty JA, Burton P, Kendall E, Ratcliffe J, Wilson A, Littlejohns P, Scuffham PA. Harnessing the potential to quantify public preferences for healthcare priorities through citizens' juries. Int J Health Policy Manag. 2014 Jun 16;3(2):57-62. doi: 10.15171/ijhpm.2014.61. eCollection 2014 Jul. PMID: 25114943; PMCID: PMC4122074.
Copy Download .nbib Format: NLM
Erratum: A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans.

Nature communications

Timpson NJ, Walter K, Min JL, Tachmazidou I, Malerba G, Shin SY, Chen L, Futema M, Southam L, Iotchkova V, Cocca M, Huang J, Memari Y, McCarthy S, Danecek P, Muddyman D, Mangino M, Menni C, Perry JR, Ring SM, Gaye A, Dedoussis G, Farmaki AE, Burton P, Talmud PJ, Gambaro G, Spector TD, Smith GD, Durbin R, Richards JB, Humphries SE, Zeggini E, Soranzo N.
PMID: 25962519
Nat Commun. 2015 May 12;6:7171. doi: 10.1038/ncomms8171.

No abstract available.

Cite
Timpson NJ, Walter K, Min JL, et al. Erratum: A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans. Nat Commun. 2015;6:7171doi: 10.1038/ncomms8171.
Timpson, N. J., Walter, K., Min, J. L., Tachmazidou, I., Malerba, G., Shin, S. Y., Chen, L., Futema, M., Southam, L., Iotchkova, V., Cocca, M., Huang, J., Memari, Y., McCarthy, S., Danecek, P., Muddyman, D., Mangino, M., Menni, C., Perry, J. R., Ring, S. M., Gaye, A., Dedoussis, G., Farmaki, A. E., Burton, P., Talmud, P. J., Gambaro, G., Spector, T. D., Smith, G. D., Durbin, R., Richards, J. B., Humphries, S. E., Zeggini, E., Soranzo, N. (2015). Erratum: A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans. Nature communications, 67171. https://doi.org/10.1038/ncomms8171
Timpson, Nicholas J, et al. "Erratum: A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans." Nature communications vol. 6 (2015): 7171. doi: https://doi.org/10.1038/ncomms8171
Timpson NJ, Walter K, Min JL, Tachmazidou I, Malerba G, Shin SY, Chen L, Futema M, Southam L, Iotchkova V, Cocca M, Huang J, Memari Y, McCarthy S, Danecek P, Muddyman D, Mangino M, Menni C, Perry JR, Ring SM, Gaye A, Dedoussis G, Farmaki AE, Burton P, Talmud PJ, Gambaro G, Spector TD, Smith GD, Durbin R, Richards JB, Humphries SE, Zeggini E, Soranzo N. Erratum: A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans. Nat Commun. 2015 May 12;6:7171. doi: 10.1038/ncomms8171. PMID: 25962519; PMCID: PMC4462837.
Copy Download .nbib Format: NLM
From inclusion to independence--training consumers to review research.

Health research policy and systems

Saunders C, Girgis A, Butow P, Crossing S, Penman A.
PMID: 18328108
Health Res Policy Syst. 2008 Mar 09;6:3. doi: 10.1186/1478-4505-6-3.

Health and medical research invariably impacts on the lives of everyday people. Organisations in the developed world are increasingly involving the public in health research projects, and research governance structures and processes. The form the involvement takes varies, as...

Cite
Saunders C, Girgis A, Butow P, et al. From inclusion to independence--training consumers to review research. Health Res Policy Syst. 2008;6:3doi: 10.1186/1478-4505-6-3.
Saunders, C., Girgis, A., Butow, P., Crossing, S., & Penman, A. (2008). From inclusion to independence--training consumers to review research. Health research policy and systems, 63. https://doi.org/10.1186/1478-4505-6-3
Saunders, Carla, et al. "From inclusion to independence--training consumers to review research." Health research policy and systems vol. 6 (2008): 3. doi: https://doi.org/10.1186/1478-4505-6-3
Saunders C, Girgis A, Butow P, Crossing S, Penman A. From inclusion to independence--training consumers to review research. Health Res Policy Syst. 2008 Mar 09;6:3. doi: 10.1186/1478-4505-6-3. PMID: 18328108; PMCID: PMC2292183.
Copy Download .nbib Format: NLM
Validity of polygraphs.

Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference

Suryanarayanan P, Kumar D, Burton P.
PMID: 17282408
Conf Proc IEEE Eng Med Biol Soc. 2005;2005:1200-3. doi: 10.1109/IEMBS.2005.1616639.

Electrodermal Activity is extensively used for measuring human emotions. Validity and reliability have been questioned by some researchers. This paper reports on highly controlled experiments to determine the validity of electrodermal al activity for measuring human emotions. The authors...

Cite
Suryanarayanan P, Kumar D, Burton P. Validity of polygraphs. Conf Proc IEEE Eng Med Biol Soc. 2005;2005:1200-3doi: 10.1109/IEMBS.2005.1616639.
Suryanarayanan, P., Kumar, D., & Burton, P. (2005). Validity of polygraphs. Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference, 20051200-3. https://doi.org/10.1109/IEMBS.2005.1616639
Suryanarayanan, Prashant, et al. "Validity of polygraphs." Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference vol. 2005 (2005): 1200-3. doi: https://doi.org/10.1109/IEMBS.2005.1616639
Suryanarayanan P, Kumar D, Burton P. Validity of polygraphs. Conf Proc IEEE Eng Med Biol Soc. 2005;2005:1200-3. doi: 10.1109/IEMBS.2005.1616639. PMID: 17282408.
Copy Download .nbib Format: NLM
Measuring the mutual diffusion coefficient for dodecyl acrylate in low molecular weight poly(dodecyl acrylate) with laser line deflection (Wiener's Method) and the fluorescence of pyrene.

The journal of physical chemistry. B

Antrim D, Bunton P, Lewis LL, Zoltowski BD, Pojman JA.
PMID: 16852454
J Phys Chem B. 2005 Jun 16;109(23):11842-9. doi: 10.1021/jp0502609.

Diffusion of small molecules into glassy polymers is quite complicated and almost always non-Fickian. Little work has been done with the diffusion of low molecular weight polymers that are liquids at room temperature (such as poly(dodecyl acrylate)) into their...

Cite
Antrim D, Bunton P, Lewis LL, et al. Measuring the mutual diffusion coefficient for dodecyl acrylate in low molecular weight poly(dodecyl acrylate) with laser line deflection (Wiener's Method) and the fluorescence of pyrene. J Phys Chem B. 2005;109(23):11842-9doi: 10.1021/jp0502609.
Antrim, D., Bunton, P., Lewis, L. L., Zoltowski, B. D., & Pojman, J. A. (2005). Measuring the mutual diffusion coefficient for dodecyl acrylate in low molecular weight poly(dodecyl acrylate) with laser line deflection (Wiener's Method) and the fluorescence of pyrene. The journal of physical chemistry. B, 109(23), 11842-9. https://doi.org/10.1021/jp0502609
Antrim, Daniel, et al. "Measuring the mutual diffusion coefficient for dodecyl acrylate in low molecular weight poly(dodecyl acrylate) with laser line deflection (Wiener's Method) and the fluorescence of pyrene." The journal of physical chemistry. B vol. 109,23 (2005): 11842-9. doi: https://doi.org/10.1021/jp0502609
Antrim D, Bunton P, Lewis LL, Zoltowski BD, Pojman JA. Measuring the mutual diffusion coefficient for dodecyl acrylate in low molecular weight poly(dodecyl acrylate) with laser line deflection (Wiener's Method) and the fluorescence of pyrene. J Phys Chem B. 2005 Jun 16;109(23):11842-9. doi: 10.1021/jp0502609. PMID: 16852454.
Copy Download .nbib Format: NLM
The mystery of the shroud.

Science (New York, N.Y.)

Bunow B.
PMID: 17738512
Science. 1978 Sep 01;201(4358):774. doi: 10.1126/science.201.4358.774-e.

No abstract available.

Cite
Bunow B. The mystery of the shroud. Science. 1978;201(4358):774doi: 10.1126/science.201.4358.774-e.
Bunow, B. (1978). The mystery of the shroud. Science (New York, N.Y.), 201(4358), 774. https://doi.org/10.1126/science.201.4358.774-e
Bunow, B. "The mystery of the shroud." Science (New York, N.Y.) vol. 201,4358 (1978): 774. doi: https://doi.org/10.1126/science.201.4358.774-e
Bunow B. The mystery of the shroud. Science. 1978 Sep 01;201(4358):774. doi: 10.1126/science.201.4358.774-e. PMID: 17738512.
Copy Download .nbib Format: NLM
Effects of growth conditions of acetate utilization byRhodopseudomonas palustris isolated from a freshwater lake.

Microbial ecology

Butow B, Dan TB.
PMID: 24194346
Microb Ecol. 1991 Dec;22(1):317-28. doi: 10.1007/BF02540233.

Rhodopseudomonas palustris, a purple non-sulfur bacterium, was recently found throughout the water column in Lake Kinneret. It was demonstrated to be of a versatile nature, growing under both aerobic and anaerobic conditions at different light intensities. A comparison of...

Cite
Butow B, Dan TB. Effects of growth conditions of acetate utilization byRhodopseudomonas palustris isolated from a freshwater lake. Microb Ecol. 1991;22(1):317-28doi: 10.1007/BF02540233.
Butow, B., & Dan, T. B. (1991). Effects of growth conditions of acetate utilization byRhodopseudomonas palustris isolated from a freshwater lake. Microbial ecology, 22(1), 317-28. https://doi.org/10.1007/BF02540233
Butow, B, and Dan, T B. "Effects of growth conditions of acetate utilization byRhodopseudomonas palustris isolated from a freshwater lake." Microbial ecology vol. 22,1 (1991): 317-28. doi: https://doi.org/10.1007/BF02540233
Butow B, Dan TB. Effects of growth conditions of acetate utilization byRhodopseudomonas palustris isolated from a freshwater lake. Microb Ecol. 1991 Dec;22(1):317-28. doi: 10.1007/BF02540233. PMID: 24194346.
Copy Download .nbib Format: NLM
Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia.

Frontiers in oncology

Pfeiffer MM, Burow H, Schleicher S, Handgretinger R, Lang P.
PMID: 23641363
Front Oncol. 2013 Apr 29;3:99. doi: 10.3389/fonc.2013.00099. eCollection 2013.

Epigenetic drugs like histone deacetylase inhibitors (HDACi) and DNA-methyltransferase inhibitors (DNMTi) have been shown to be effective against a variety of tumor entities. Among different molecular anticancer activities of epigenetic active substances, up-regulation of natural killer (NK) cell ligands...

Cite
Pfeiffer MM, Burow H, Schleicher S, et al. Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia. Front Oncol. 2013;3:99doi: 10.3389/fonc.2013.00099.
Pfeiffer, M. M., Burow, H., Schleicher, S., Handgretinger, R., & Lang, P. (2013). Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia. Frontiers in oncology, 399. https://doi.org/10.3389/fonc.2013.00099
Pfeiffer, Matthias Manuel, et al. "Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia." Frontiers in oncology vol. 3 (2013): 99. doi: https://doi.org/10.3389/fonc.2013.00099
Pfeiffer MM, Burow H, Schleicher S, Handgretinger R, Lang P. Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia. Front Oncol. 2013 Apr 29;3:99. doi: 10.3389/fonc.2013.00099. eCollection 2013. PMID: 23641363; PMCID: PMC3638146.
Copy Download .nbib Format: NLM
Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer.

Oncotarget

Kluth M, Jung S, Habib O, Eshagzaiy M, Heinl A, Amschler N, Masser S, Mader M, Runte F, Barow P, Frogh S, Omari J, Möller-Koop C, Hube-Magg C, Weischenfeldt J, Korbel J, Steurer S, Krech T, Huland H, Graefen M, Minner S, Sauter G, Schlomm T, Simon R.
PMID: 29312579
Oncotarget. 2017 Nov 11;8(65):108923-108935. doi: 10.18632/oncotarget.22408. eCollection 2017 Dec 12.

Prostate cancer is characterized by recurrent deletions that can considerably vary in size. We hypothesized that large deletions develop from small deletions and that this "deletion lengthening" might have a "per se" carcinogenic role through a combinatorial effect of...

Cite
Kluth M, Jung S, Habib O, et al. Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer. Oncotarget. 2017;8(65):108923-108935doi: 10.18632/oncotarget.22408.
Kluth, M., Jung, S., Habib, O., Eshagzaiy, M., Heinl, A., Amschler, N., Masser, S., Mader, M., Runte, F., Barow, P., Frogh, S., Omari, J., Möller-Koop, C., Hube-Magg, C., Weischenfeldt, J., Korbel, J., Steurer, S., Krech, T., Huland, H., Graefen, M., Minner, S., Sauter, G., Schlomm, T., & Simon, R. (2017). Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer. Oncotarget, 8(65), 108923-108935. https://doi.org/10.18632/oncotarget.22408
Kluth, Martina, et al. "Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer." Oncotarget vol. 8,65 (2017): 108923-108935. doi: https://doi.org/10.18632/oncotarget.22408
Kluth M, Jung S, Habib O, Eshagzaiy M, Heinl A, Amschler N, Masser S, Mader M, Runte F, Barow P, Frogh S, Omari J, Möller-Koop C, Hube-Magg C, Weischenfeldt J, Korbel J, Steurer S, Krech T, Huland H, Graefen M, Minner S, Sauter G, Schlomm T, Simon R. Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer. Oncotarget. 2017 Nov 11;8(65):108923-108935. doi: 10.18632/oncotarget.22408. eCollection 2017 Dec 12. PMID: 29312579; PMCID: PMC5752492.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 222 entries